LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 2 of 2: Mean cell count and mean normalized growth rate inhibition values across technical replicates. - Dataset (ID:20260)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Selumetinib | 0.3704 | uM | 0 | uM | 2 | 1843 | 4661 | 5189 | 0.8615 | |
BT-20 | Selumetinib | 0.1235 | uM | 0 | uM | 2 | 1843 | 4583 | 5189 | 0.8380 |